Agrawal A. Pharmacological Prevention of Severe Respiratory Syncytial Virus Infection in High-Risk Infants and Children: Maternal Immunization and Long-Acting Monoclonal Antibodies. Indian J Pharm Drug Studies [Internet]. 2025 Sep. 17 [cited 2026 Nov. 15];4(3):95-101. Available from: https://mansapublishers.com/ijpds/article/view/8496